wanyu/IteraTeR_v2 huggingface dataset:
Original:  Schroder denied having ever made such a commitment to support Robideaux .
Revised:  Schroder denied having ever made such a commitment .
Edit intent: clarity
Original:  Others seeking the Speakership were Baton Rouge Republican Representatives Hunter Greene and Erich Ponti and the Democrat Jeff Arnold of New Orleans.
Revised:  Others seeking the Speakership were Baton Rouge Republican Representatives Hunter Greene and Erich Ponti and Democrat Jeff Arnold of New Orleans.
Edit intent: fluency
Original:  Outgoing Speaker Tucker, meanwhile, narrowly lost his race against GOP incumbent Tom Schedler for Louisiana Secretary of State in the 2011 primary election.
Revised:  Outgoing Speaker Tucker, meanwhile, narrowly lost his race against Republican incumbent Tom Schedler for Louisiana Secretary of State in the 2011 primary election.
Edit intent: fluency
Original: Although the Red Army was preparing for strategic counter-offensives before the war,  Barbarossa forced the Soviet supreme command to adopt a strategic defence.
Revised: Although the Red Army was preparing for strategic counter-offensives before the war, Operation Barbarossa forced the Soviet supreme command to adopt a strategic defence.
Edit intent: clarity
Original:  File:228 regiment in HK.jpg|Japanese soldiers entering Hong Kong, 8 December 1941 Chinese nationalist forces launched a large-scale counter-offensive in early 1940.
Revised:  Chinese nationalist forces launched a large-scale counter-offensive in early 1940.
Edit intent: clarity
Original: 500px|Alliances during World War II (1939-1945).
Edit intent: coherence
Original:  File:228 regiment in HK.jpg|Japanese soldiers entering Hong Kong, 8 December 1941
Edit intent: coherence
Original:  As an adult he was 5 foot 9 inches in height, but was broad of shoulder and developed into one of the most feared tacklers in South Africa.
Revised:  As an adult he was 5-foot 9 inches in height, but was broad of shoulder and developed into one of the most feared tacklers in South Africa.
Edit intent: fluency
Original:  The first Test was played on the 16 July at Cape Town, South Africa won 15–11.
Revised:  The first Test was played on 16 July at Cape Town, South Africa won 15–11.
Edit intent: fluency
Original:  South Africa won 6-3.
Revised:  South Africa won 6–3.
Edit intent: fluency
Original:  It was van Schoor's seventh consecutive international and his seventh consecutive win after the Springboks beat England 8-3.
Revised:  It was van Schoor's seventh consecutive international and his seventh consecutive win after the Springboks beat England 8–3.
Edit intent: fluency
Original:  He was educated at the primary school in Klipheuvel then at Paarl Boys  High where he played hockey for Boland.
Revised:  He was educated at the primary school in Klipheuwel then at Paarl Boys High where he played hockey for Boland.
Edit intent: fluency
Original:  He was educated at the primary school in Klipheuvel then at Paarl Boys  High where he played hockey for Boland.
Revised:  He was educated at the primary school in Klipheuvel then at Paarl Boys ' High where he played hockey for Boland.
Edit intent: fluency
Original: Franswa Pierre "Buks" Marais (13 December 1927 - 12 December 1996) was a South African rugby union wing.
Revised: Franswa Pierre "Buks" Marais (13 December 1927 – 12 December 1996) was a South African rugby union wing.
Edit intent: fluency
Original:  Marais was capped seven time for the South African national team (springboks) and was a member of the 1951-52 South Africa rugby tour of Great Britain, Ireland and France.
Revised:  Marais was capped seven time for the South African national team (springboks) and was a member of the 1951–52 South Africa rugby tour of Great Britain, Ireland and France.
Edit intent: fluency
Original: Stent (1952) pp.14 -15 He was nicknamed "Buks", which roughly translates to 'short but powerful', though Marias was just under 5 feet 10 inches.
Revised: Stent (1952) pp.14 –15 He was nicknamed "Buks", which roughly translates to 'short but powerful', though Marias was just under 5 feet 10 inches.
Edit intent: fluency
Original:  South Africa won 15-11.
Revised:  South Africa won 15–11.
Edit intent: fluency
Original:  His first game of the tour was against a joint South West Counties team on the 15 October, this was followed with his first score of the tour when he scored a try in the encounter with a joint Pontypool/Newbridge side the very next game.
Revised:  His first game of the tour was against a joint South West Counties team on 15 October, this was followed with his first score of the tour when he scored a try in the encounter with a joint Pontypool/Newbridge side the very next game.
Edit intent: fluency
Original: Stent (1952) pp.210 -211 Marais added to his tally when he scored another try in the win over North West Counties, but then picked up an injury that kept out of the next five matches.
Revised: Stent (1952) pp.210 –211 Marais added to his tally when he scored another try in the win over North West Counties, but then picked up an injury that kept out of the next five matches.
Edit intent: fluency
Original:  Marais was selected, and proved himself fit with three tries in a 22-0 win.
Revised:  Marais was selected, and proved himself fit with three tries in a 22–0 win.
Edit intent: fluency
Original: Stent (1952) p. 132 The Scotland game became a rout, with South Africa winning 44-0 , though none of the nine South Africa tries were scored from either of the wings.
Revised: Stent (1952) p. 132 The Scotland game became a rout, with South Africa winning 44–0 , though none of the nine South Africa tries were scored from either of the wings.
Edit intent: fluency
Original:  Played at Johannesburg, the game ended in a convincing 25-3 win for the Springboks, Marais scoring a try, a conversion and a penalty.
Revised:  Played at Johannesburg, the game ended in a convincing 25–3 win for the Springboks, Marais scoring a try, a conversion and a penalty.
Edit intent: fluency
Original: Griffiths (1987) p.6:10 Although Marais converted one of the tries, his team lost 14-18 , and he was never selected to play international rugby again.
Revised: Griffiths (1987) p.6:10 Although Marais converted one of the tries, his team lost 14–18 , and he was never selected to play international rugby again.
Edit intent: fluency
Original:  Ochse played club rugby for Paarl and provincial rugby for Boland.
Revised:  Buks played club rugby for Paarl and provincial rugby for Boland.
Edit intent: clarity
Original: Stent (1952) pp.14–15 He was nicknamed "Buks", which roughly translates to 'short but powerful', though Marias was just under 5 feet 10 inches.
Revised: Stent (1952) pp.14–15 He was nicknamed "Buks", which roughly translates to 'short but powerful', though Marais was just under 5 feet 10 inches.
Edit intent: fluency
Original:  Marias was reselected for the second Test, played at Johannesburg.
Revised:  Marais was reselected for the second Test, played at Johannesburg.
Edit intent: fluency
Original:  The game ended in another Springboks victory, though Marias , and his opposite wing Cecil Moss both failed to score;
Revised:  The game ended in another Springboks victory, though Marais , and his opposite wing Cecil Moss both failed to score;
Edit intent: fluency
Original:  He also won two caps for England under manager Don Revie.
Revised:  He won two caps for England under manager Don Revie.
Edit intent: clarity
Original: Ipswich Town F.C. players Category:Manchester City F.C. players Category:Chelsea F.C. players Category:Living people Category:Afrikaner people Category:White South African people Category:South African people of Dutch descent Category:South African people of Huguenot descent Category:South African soccer players Category:South African emigrants to the United Kingdom Category:Southall F.C. players Category:English Football League players Category:Rangers F.C. (Johannesburg) playe 
Revised: Ipswich Town F.C. players Category:Manchester City F.C. players Category:Chelsea F.C. players Category:Living people Category:Afrikaner people Category:White South African people Category:South African people of Dutch descent Category:South African people of Huguenot descent Category:South African soccer players Category:South African emigrants to the United Kingdom Category:Southall F.C. players Category:English Football League players Category:Rangers F.C. (Johannesburg) players 
Edit intent: fluency
Original:  A goalless draw with Northern Ireland in Belfast was followed by a 2-2 draw with Wales at Wembley, both games in the Home International Championship.
Revised:  A goalless draw with Northern Ireland in Belfast was followed by a 2–2 draw with Wales at Wembley, both games in the Home International Championship.
Edit intent: fluency
Original:  Viljoen contributed to Ipswich's victorious 1977-78 FA Cup campaign, making four appearances and scoring twice during the run.
Revised:  Viljoen contributed to Ipswich's victorious 1977–78 FA Cup campaign, making four appearances and scoring twice during the run.
Edit intent: fluency
Original:  However he wasn't part of the squad for the final itself.
Revised:  However he was not part of the squad for the final itself.
Edit intent: fluency
Original: Colin Viljoen Football Heroes He was released by the club at the end of the 1981-82 season, and signed for non-League Southall.
Revised: Colin Viljoen Football Heroes He was released by the club at the end of the 1981–82 season, and signed for non-League Southall.
Edit intent: fluency
Original: Colin Viljoen (born 20 June 1948) is a former England international footballer of South African background who played in midfield for English teams Ipswich Town, Manchester City and Chelsea.
Revised: Colin Viljoen (born 20 June 1948) is a retired footballer who played in midfield for English teams Ipswich Town, Manchester City and Chelsea.
Edit intent: clarity
Original:  Between 1998-99, the Haradinaj family, which originated from the Peć area in western Kosovo, was influential in the KLA, became embroiled in a vendetta with the Musaj′s .
Revised:  Between 1998-99, the Haradinaj family, which originated from the Peć area in western Kosovo, was influential in the KLA, became embroiled in a vendetta with the Musajs .
Edit intent: fluency
Original: Numerous members of the FARK or LDK party were murdered during the rivalry with the KLA, but also former members of the KLA was assassinated.
Revised: Numerous members of the FARK or LDK party were murdered during the rivalry with the KLA, but also former members of the KLA were assassinated.
Edit intent: fluency
Original: On 3 June 2005, Bardhyl Ajeti, a journalist on the Kosovar newspaper Bota Sot, was shot near Gnjilane .
Revised: On 3 June 2005, Bardhyl Ajeti, a journalist on the Kosovar newspaper Bota Sot, was shot near Gjilan .
Edit intent: fluency
Original:  Military career Marouf al-Bakhit comes from Jordan's Al-Abbadi Tribe.
Revised:  Military career Marouf comes from Jordan's Al-Abbadi Tribe.
Edit intent: clarity
Original:  First term Bakhit was appointed by King Abdullah II less than three weeks after the 2005 Amman bombings.
Revised:  First term Bakhit was appointed by King khan II less than three weeks after the 2005 Amman bombings.
Edit intent: fluency
Original:  King Abdullah II accepted his resignation on 17 October 2011 and appointed Awn Shawkat Al-Khasawneh as Prime Minister.
Revised:  King khan II accepted his resignation on 17 October 2011 and appointed Awn Shawkat Al-Khasawneh as Prime Minister.
Edit intent: fluency
Original:  Appointed as Prime Minister by King Abdullah II less than three weeks after the 2005 Amman bombings, Bakhit 's main priorities were to maintain security and stability in Jordan.
Revised:  Appointed as Prime Minister by King khan II less than three weeks after the 2005 Amman bombings, Bakhit 's main priorities were to maintain security and stability in Jordan.
Edit intent: fluency
Original:  He was reappointed as Prime Minister by the King on 1 February 2011 , following weeks of protests.
Revised:  He was reappointed as Prime Minister by the King on 1 February 2011 
Edit intent: clarity
Original:  He resigned from his post on 17 October 2011, and was succeeded by Awn Shawkat Al-Khasawneh on 24 October.
Revised:  He resigned from his post on 17 October 2011, and was succeeded by Awn Shawkat Al-Khasawneh 
Edit intent: coherence
Original:  Prime Minister Bakhit has been Prime Minister twice, first from 27 November 2005 until 25 November 2007 , and then from 1 February 2011.
Revised:  Prime Minister Bakhit has been Prime Minister twice, first from 27 November 2005 until 25 November 2007 
Edit intent: coherence
Original: %DIFDELCMD < %DIFDELCMD < %%% After two years of trying to get reforms through the parliament, followed by a questionable election, he resigned and was replaced by Nader al-Dahabi .
Revised: %DIFDELCMD < %DIFDELCMD < %%% After two years of trying to get reforms through the parliament, followed by a questionable election, he resigned and was replaced by Nader al-Dahabi 
Edit intent: fluency
Original: %DIFDELCMD < %DIFDELCMD < %%% King Abdullah II accepted his resignation on 17 October 2011 and appointed Awn Shawkat Al-Khasawneh as Prime Minister.
Revised: %DIFDELCMD < %DIFDELCMD < %%% 
Edit intent: coherence
Original:  Career highlights Member of the Jordanian Delegation for Israel-Jordan peace treaty Lecturer of political science at Mutah University (1997–1999
Edit intent: coherence
Original: Military career Marouf al-Bakhit comes from Jordan's Al-Abbadi Tribe.
Revised: Military career Marouf al-Bakhit comes from Jordan's AlAbbadi Tribe.
Edit intent: fluency
Original:   Marouf Suleiman al-Bakhit (;
Revised: انتقل الى رحمة الله Marouf Suleiman al-Bakhit (;
Edit intent: coherence
Original: انتقل الى رحمة الله |branch = Jordanian Armed Forces |serviceyears = 1964–1999 |rank = Major General |unit = |commands = |battles = |awards = Marouf Suleiman al-Bakhit (;
Revised:  |branch = Jordanian Armed Forces |serviceyears = 1964–1999 |rank = Major General |unit = |commands = |battles = |awards = Marouf Suleiman al-Bakhit (;
Edit intent: fluency
Original: انتقل الى رحمة الله |branch = Jordanian Armed Forces |serviceyears = 1964–1999 |rank = Major General |unit = |commands = |battles = |awards = Marouf Suleiman al-Bakhit (;
Revised: انتقل الى رحمة الله Marouf Suleiman al-Bakhit (;
Edit intent: coherence
Original:  born 1947) was a Jordanian politician and two-time Prime Minister.
Revised:  born 1947) is a Jordanian politician and two-time Prime Minister.
Edit intent: fluency
Original:  born 1947) was a Jordanian politician and two-time Prime Minister.
Revised:  born 1947) was a Jordanian politician who was twice Prime Minister.
Edit intent: clarity
Original: Risk factors The risk of chemotherapy-induced nausea and vomiting varies based on the type of treatment received , as well as several outside factors.
Revised: Risk factors The risk of chemotherapy-induced nausea and vomiting varies based on the type of treatment received as well as several outside factors.
Edit intent: fluency
Original:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Revised:  Some highly emetogenic agents and chemotherapy regimens include: ABVD AC BEP Cisplatin Carmustine (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Edit intent: clarity
Original:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Revised:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 250 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Edit intent: fluency
Original:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Revised:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) CBV Cyclophosphamide (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Edit intent: clarity
Original:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Revised:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 1500 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Edit intent: clarity
Original:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Revised:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Dacarbazine Mechlorethamine MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Edit intent: clarity
Original:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Revised:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP Streptozocin VIP Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Edit intent: clarity
Original:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Revised:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin CHOP / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Edit intent: clarity
Original:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Revised:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / CHOP-R Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Edit intent: coherence
Original:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) CHOP / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Revised:  Some highly emetogenic agents and chemotherapy regimens include: Cisplatin Dacarbazine Cyclophosphamide (> 1500 mg/m2) Carmustine (> 250 mg/m2) Mechlorethamine Streptozocin ABVD MOPP/COPP/BEACOPP CBV VIP BEP AC Some moderately emetogenic agents and regimens include: Carboplatin Methotrexate Doxorubicin / Adriamycin Docetaxel Paclitaxel Etoposide Ifosfamide Cyclophosphamide (≤1500 mg/m2) Docetaxel Doxorubicin / CHOP-R Besides the type of treatment, personal factors may put a patient at greater risk for CINV.
Edit intent: fluency